Successful immunomodulators for the treatment of COVID-19 have opened the pathway for comparative trials

Saved in:
Bibliographic Details
Published in:Clinical microbiology and infection 2023-01, Vol.29 (1), p.7-9
Main Authors: Gallagher, Jason C., Morgan, Rebecca L.
Format: Article
Language:English
Subjects:
Baricitinib
COVID-19
COVID-19 - therapy
Humans
IL6 inhibitor
Immunologic Factors - therapeutic use
Sarilumab
SARS-CoV-2
Tocilizumab
Treatment Outcome
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:
ISSN:1198-743X
1469-0691
1469-0691
DOI:10.1016/j.cmi.2022.10.016